NAICS 325411 - Medicinal and Botanical Manufacturing
This U.S. industry comprises establishments primarily engaged in (1) manufacturing uncompounded medicinal chemicals and their derivatives (i.e., generally for use by pharmaceutical preparation manufacturers) and/or (2) grading, grinding, and milling uncompounded botanicals.
Industry trends:
The NAICS 325411, Medicinal and Botanical Manufacturing industry is seeing significant qualitative trends driven by a combination of technological advancements, regulatory changes, and consumer preferences. One of the most notable trends is the increased integration of artificial intelligence (AI) and machine learning in research and development processes. These technologies are improving the efficiency and accuracy of drug discovery, thereby accelerating time-to-market for new medicinal products.
Another trend is the growing consumer demand for natural and plant-based medicinal products. This shift is largely influenced by increasing awareness of the potential side effects of synthetic drugs and a general trend towards holistic and preventive healthcare. Consequently, companies are investing more in the development and marketing of botanical-based medicines and supplements.
Regulatory landscapes are also evolving, with stricter quality controls and compliance requirements being enforced by agencies like the FDA and EMA. This has led to the adoption of more robust quality assurance processes and greater transparency in manufacturing practices.
Looking ahead, the industry is expected to continue its growth trajectory with an emphasis on personalized medicine and targeted therapies. Advances in genomics and biotechnology are setting the stage for more customized treatment plans that cater to individual genetic profiles. Additionally, sustainability practices are becoming more prominent, driven by both regulatory pressures and consumer demand for eco-friendly products. These trends suggest a future where innovation and responsibility go hand in hand, fostering a more efficient and ethical industry.
This industry is comprised of:
Acetylsalicylic acid manufacturing
Adrenal derivatives, uncompounded, manufacturing
Agar-agar grinding manufacturing
Amphetamines, uncompounded, manufacturing
Anesthetics, uncompounded, manufacturing
Antibiotics, uncompounded, manufacturing
Anticholinergics, uncompounded, manufacturing
Anticonvulsants, uncompounded, manufacturing
Antidepressants, uncompounded, manufacturing
Ascorbic acid (i.e., vitamin C), uncompounded, manufacturing
Atropine and derivatives manufacturing
Barbiturates, uncompounded, manufacturing
Barbituric acid manufacturing
Brucine manufacturing
Caffeine and derivatives (i.e., basic chemicals) manufacturing
Cephalosporin, uncompounded, manufacturing
Cinchona and derivatives (i.e., basic chemicals) manufacturing
Cocaine and derivatives (i.e., basic chemicals) manufacturing
Cod liver oil, medicinal, uncompounded, manufacturing
Codeine and derivatives (i.e., basic chemicals) manufacturing
Concentrated medicinal chemicals, uncompounded, manufacturing
Cortisone, uncompounded ,manufacturing
Digitoxin, uncompounded, manufacturing
Endocrine products, uncompounded, manufacturing
Enzyme proteins (i.e., basic synthetic chemicals), pharmaceutical use, manufacturing
Ephedrine and derivatives (i.e., basic chemicals) manufacturing
Ergot alkaloids (i.e., basic chemicals) manufacturing
Fish liver oils, medicinal, uncompounded, manufacturing
Glandular derivatives, uncompounded, manufacturing
Glycosides, uncompounded, manufacturing
Grinding and milling botanicals (i.e., for medicinal use)
Hormones and derivatives, uncompounded, manufacturing
Hypnotic drugs, uncompounded, manufacturing
Insulin, uncompounded, manufacturing
Magnesia, medicinal, uncompounded, manufacturing
Medicinal chemicals, uncompounded, manufacturing
Morphine and derivatives (i.e., basic chemicals) manufacturing
Nicotine and derivatives (i.e., basic chemicals) manufacturing
N-methylpiperazine manufacturing
Oils, vegetable and animal, medicinal, uncompounded, manufacturing
Ophthalmic agents, uncompounded, manufacturing
Opium and opium derivatives (i.e., basic chemicals) manufacturing
Penicillin, uncompounded, manufacturing
Physostigmine and derivatives (i.e., basic chemicals) manufacturing
Pituitary gland derivatives, uncompounded, manufacturing
Procaine and derivatives (i.e., basic chemicals) manufacturing
Quinine and derivatives (i.e., basic chemicals) manufacturing
Reserpines (i.e., basic chemicals) manufacturing
Salicylic acid, medicinal, uncompounded, manufacturing
Steriods, uncompounded, manufacturing
Strychnine and derivatives (i.e., basic chemicals) manufacturing
Sulfa drugs, uncompounded, manufacturing
Sulfonamides, uncompounded, manufacturing
Tetracycline, uncompounded, manufacturing
Theobromine and derivatives (i.e., basic chemicals) manufacturing
Vegetable alkaloids (i.e., basic chemicals) (e.g., caffeine, codeine, morphine, nicotine), manufacturing
Vitamins, uncompounded, manufacturing
This report includes the ability to segment your Industry by:
- Region
- Employees
- Net Sales
- Company Age
- Total Assets
- Ownership Type
With iCFO You Get
What Is iCFO?
A review and comparison of financial performance of privately-help companies in specified SIC/NAICS industry segment, using industry standard benchmarks.
Sound Business Analysis
Answers come easily with iCFO. Review ROI, sales per employee, profit margins of the top 10%, top 25% and more, to identify areas of concern and opportunity. Examine what if scenarios and P&L impact of reducing costs or adding revenue.
Your Business’ Health In Minutes
It takes only five minutes to enter your data and produce a concise profile of your company’s fiscal state, including critical business ratios focusing on liquidity, profitability, asset efficiency, and growth.